{
    "name": "olipudase alfa",
    "comment": "Rx",
    "other_names": [
        "Xenpozyme",
        "olipudase alfa-rpcp"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/xenpozyme-olipudase-alfa-4000297",
    "pregnancy": {
        "common": [
            "Based on findings from animal reproduction studies, may cause embryo-fetal harm when administered to pregnant females",
            "Dosage initiation or escalation, at any time during pregnancy, is not recommended as it may lead to elevated sphingomyelin metabolite levels that may increase risk of fetal malformations",
            "However, the decision to continue or discontinue maintenance dosing in pregnancy should consider the femaleâ€™s need for the drug and potential drug-related risks to the fetus, and potential adverse outcomes from untreated maternal ASMD disease",
            "Data are not available on presence in human milk, effects on breastfed infants, or effects on milk production",
            "Present in animal milk; when a drug is present in animal milk, it is likely that the drug will be present in human milk"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In pregnant mice, exencephaly was observed in offspring at an exposure less than the exposure at the maximum recommended human dose"
                ]
            },
            {
                "type": "Contraception ",
                "description": [
                    "Verify pregnancy status in females of reproductive potential before initiating",
                    "Advise females of reproductive potential to use effective contraception during treatment and for 14 days after last dose if olipudase alfa is discontinued"
                ]
            },
            {
                "type": "Animal data ",
                "description": [
                    "Administered as a single IV dose (3 mg/kg) to lactating mice on post-partum day 7",
                    "Milk was not evaluated until post-partum day 9, at which time concentrations detected were ~1.3% the estimated maximal maternal plasma concentration"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Hypersensitivity reactions including anaphylaxis ",
                    "description": [
                        "Appropriate medical support measures, including cardiopulmonary resuscitation equipment, need to be readily available",
                        "If severe hypersensitivity reaction occurs, discontinued immediately and initiate appropriate medical treatment"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "None",
                "May cause fetal harm"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "54"
        },
        {
            "name": "Cough",
            "percent": "31"
        },
        {
            "name": "Diarrhea",
            "percent": "15"
        },
        {
            "name": "Hypotension",
            "percent": "15"
        },
        {
            "name": "Ocular hyperemia",
            "percent": "15"
        },
        {
            "name": "Elevated transaminase levels",
            "percent": "13"
        },
        {
            "name": "Pyrexia",
            "percent": "100"
        },
        {
            "name": "Cough",
            "percent": "75"
        },
        {
            "name": "Diarrhea",
            "percent": "75"
        },
        {
            "name": "Rhinitis",
            "percent": "75"
        },
        {
            "name": "Abdominal pain",
            "percent": "63"
        },
        {
            "name": "Vomiting",
            "percent": "50"
        },
        {
            "name": "Headache",
            "percent": "50"
        },
        {
            "name": "Urticaria",
            "percent": "50"
        },
        {
            "name": "Nausea",
            "percent": "38"
        },
        {
            "name": "Rash",
            "percent": "38"
        },
        {
            "name": "Arthralgia",
            "percent": "38"
        },
        {
            "name": "Pruritus",
            "percent": "25"
        },
        {
            "name": "Fatigue",
            "percent": "25"
        },
        {
            "name": "Pharyngitis",
            "percent": "25"
        },
        {
            "name": "C",
            "percent": "13"
        },
        {
            "name": "reactive protein increased",
            "percent": "13"
        },
        {
            "name": "Hypotension",
            "percent": "13"
        },
        {
            "name": "Anaphylactic reaction",
            "percent": "13"
        },
        {
            "name": "Hypersensitivity",
            "percent": "13"
        },
        {
            "name": "Infusion site swelling",
            "percent": "13"
        },
        {
            "name": "Tachycardia",
            "percent": "13"
        },
        {
            "name": "Pharyngeal swelling",
            "percent": "13"
        },
        {
            "name": "Elevated transaminase levels",
            "percent": "8"
        },
        {
            "name": "Erythema",
            "percent": "8"
        },
        {
            "name": "Asthenia",
            "percent": "8"
        },
        {
            "name": "Pharyngitis",
            "percent": "8"
        },
        {
            "name": "Dyspnea",
            "percent": "8"
        },
        {
            "name": "Urticaria",
            "percent": "8"
        },
        {
            "name": "Papule",
            "percent": "8"
        },
        {
            "name": "Myalgia",
            "percent": "8"
        },
        {
            "name": "Throat irritation",
            "percent": "8"
        },
        {
            "name": "C",
            "percent": null
        },
        {
            "name": "reactive protein abnormal",
            "percent": null
        }
    ]
}